Related Experiment Video
Updated: Jun 21, 2025

09:12
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia
Published on: February 3, 2023
2.4K
Causality of immune cells on primary sclerosing cholangitis: a bidirectional two-sample Mendelian randomization study
Pu Wu1,2,3, Sinan Xie1,2,3, Yunshi Cai1,2,3
1Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
Frontiers in Immunology
|July 16, 2024
Summary
This study used Mendelian randomization to investigate causal links between primary sclerosing cholangitis (PSC) and immune cells. Certain immune cell markers are linked to PSC risk, suggesting potential therapeutic targets.
Area of Science:
- Immunology
- Genetics
- Gastroenterology
Background:
- Primary sclerosing cholangitis (PSC) is associated with immune dysregulation, particularly involving intestinal immune cells.
- The causal relationship between peripheral blood immune cells and PSC is not well understood.
Purpose of the Study:
- To investigate the causal effects between peripheral blood immune cells and primary sclerosing cholangitis (PSC) using a bidirectional two-sample Mendelian randomization analysis.
- To identify specific immune cell markers that may causally influence PSC risk.
Main Methods:
- A bidirectional two-sample Mendelian randomization (MR) analysis was performed using publicly available genetic data.
- The inverse variance weighted (IVW) method was the primary analysis technique, with heterogeneity and pleiotropy assessed using Cochran's Q statistics and MR-Egger intercept.
Main Results:
- Forward MR analysis revealed that increased expression of CD11c on myeloid dendritic cells (DCs) and CD62L-myeloid DC AC were associated with higher PSC risk.
- Conversely, increased CD28 on resting regulatory T cells (Tregs) and CD3 on secreting Tregs were negatively associated with PSC risk.
- Reverse MR analysis indicated a genetic causal effect of PSC on various CD8+ T cell subsets.
Conclusions:
- This study provides evidence for causal relationships between specific peripheral blood immune cells and primary sclerosing cholangitis (PSC).
- These findings may offer a foundation for developing novel diagnostic and therapeutic strategies for PSC.

